Search research articles
Contact Us
Filters
Showing results (31-40 of 109) with videos related to
Page
of 11
Sort By:
Expert Opinion on Therapeutic Patents
|
January 4, 2021
Soluble guanylate cyclase stimulators and their potential use: a patent review
Peter Sandner, Alexandros Vakalopoulos, Michael G Hahn, et al.
Biochemical Pharmacology
|
January 6, 2025
Runcaciguat activates soluble guanylyl cyclase via the histidine essential for heme binding and nitric oxide activation
Theresa Wittrien, Anne Rühle, Christin Elgert, et al.
European Journal of Pharmacology
|
December 7, 2024
Soluble guanylyl cyclase stimulators and activators: Promising drugs for the treatment of hypertension?
Olga Gawrys, Petr Kala, Janusz Sadowski, et al.
International Journal of Molecular Sciences
|
June 13, 2018
The Impact of the Nitric Oxide (NO)/Soluble Guanylyl Cyclase (sGC) Signaling Cascade on Kidney Health and Disease: A Preclinical Perspective
Shalini M Krishnan, Jan R Kraehling, Frank Eitner, et al.
Biochemical Pharmacology
|
September 23, 2025
Exploring the potential of soluble guanylyl cyclase stimulators and activators in heart failure
Olga Gawrys, Petr Kala, Michal Šnorek, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
March 20, 2024
The nitric oxide-soluble guanylate cyclase-cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase
Raymond L Benza, Ekkehard Grünig, Peter Sandner, et al.
Circulation. Heart Failure
|
December 6, 2021
Vericiguat Improves Aortic Wave Reflection Parameters in a New Preclinical Model of Hypertension
Katharina Boden, Peter Sandner, Lothar Roessig, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
June 16, 2009
Vardenafil protects against myocardial and endothelial injuries after cardiopulmonary bypass
Gábor Szabó, Tamás Radovits, Gábor Veres, et al.
British Journal of Pharmacology
|
August 20, 2019
Mind the gap (junction): cGMP induced by nitric oxide in cardiac myocytes originates from cardiac fibroblasts
Lukas Menges, Christian Krawutschke, Ernst-Martin Füchtbauer, et al.
European Urology
|
November 2, 2010
Vardenafil decreases bladder afferent nerve activity in unanesthetized, decerebrate, spinal cord-injured rats
Delphine Behr-Roussel, Stephanie Oger, Stéphanie Caisey, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 109) with videos related to
Sort By:
Page
of 11
Expert Opinion on Therapeutic Patents
|
January 4, 2021
Soluble guanylate cyclase stimulators and their potential use: a patent review
Peter Sandner, Alexandros Vakalopoulos, Michael G Hahn, et al.
Biochemical Pharmacology
|
January 6, 2025
Runcaciguat activates soluble guanylyl cyclase via the histidine essential for heme binding and nitric oxide activation
Theresa Wittrien, Anne Rühle, Christin Elgert, et al.
European Journal of Pharmacology
|
December 7, 2024
Soluble guanylyl cyclase stimulators and activators: Promising drugs for the treatment of hypertension?
Olga Gawrys, Petr Kala, Janusz Sadowski, et al.
International Journal of Molecular Sciences
|
June 13, 2018
The Impact of the Nitric Oxide (NO)/Soluble Guanylyl Cyclase (sGC) Signaling Cascade on Kidney Health and Disease: A Preclinical Perspective
Shalini M Krishnan, Jan R Kraehling, Frank Eitner, et al.
Biochemical Pharmacology
|
September 23, 2025
Exploring the potential of soluble guanylyl cyclase stimulators and activators in heart failure
Olga Gawrys, Petr Kala, Michal Šnorek, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
March 20, 2024
The nitric oxide-soluble guanylate cyclase-cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase
Raymond L Benza, Ekkehard Grünig, Peter Sandner, et al.
Circulation. Heart Failure
|
December 6, 2021
Vericiguat Improves Aortic Wave Reflection Parameters in a New Preclinical Model of Hypertension
Katharina Boden, Peter Sandner, Lothar Roessig, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
June 16, 2009
Vardenafil protects against myocardial and endothelial injuries after cardiopulmonary bypass
Gábor Szabó, Tamás Radovits, Gábor Veres, et al.
British Journal of Pharmacology
|
August 20, 2019
Mind the gap (junction): cGMP induced by nitric oxide in cardiac myocytes originates from cardiac fibroblasts
Lukas Menges, Christian Krawutschke, Ernst-Martin Füchtbauer, et al.
European Urology
|
November 2, 2010
Vardenafil decreases bladder afferent nerve activity in unanesthetized, decerebrate, spinal cord-injured rats
Delphine Behr-Roussel, Stephanie Oger, Stéphanie Caisey, et al.
Page
of 11